Correlation Between Eliem Therapeutics and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Entrada Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Entrada Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Entrada Therapeutics
-0.87 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Eliem and Entrada is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Entrada Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Entrada Therapeutics. In addition to that, Eliem Therapeutics is 1.61 times more volatile than Entrada Therapeutics. It trades about -0.28 of its total potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.16 per unit of volatility. If you would invest 1,645 in Entrada Therapeutics on August 28, 2024 and sell it today you would earn a total of 292.00 from holding Entrada Therapeutics or generate 17.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 95.35% |
| Values | Daily Returns |
Eliem Therapeutics vs. Entrada Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Entrada Therapeutics |
Eliem Therapeutics and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Entrada Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Entrada Therapeutics vs. Molecular Partners AG | Entrada Therapeutics vs. Pmv Pharmaceuticals | Entrada Therapeutics vs. Monte Rosa Therapeutics | Entrada Therapeutics vs. Vigil Neuroscience |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |